PBT-4

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePBT-4
Drug Alias NameMPAC (Prana)metal protein attenuating compounds (Prana)Neuroprotectant (Prana)PBT-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectantsChelating agents
TargetsUpdating
Therapy Area/IndicationsMacular DegenerationAlzheimer DiseaseParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlterity Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlterity Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsMacular DegenerationAlzheimer DiseaseParkinson Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A